Better integration of clinical features with molecular and genomic data may help to establish a more reliable regression grading system that could serve as a future predictor of outcomes for patients with resectable esophageal cancer. See also pages 000-000.
http://ift.tt/2webvrR
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου